DEA Archived Press Releases

Press Releases before January 20, 2025
1340 Results - Showing 1291 to 1300
PRESS RELEASE

Seventeen defendants charged in takedown of Newark’s ‘Famous Boyz’ street gang

NEWARK, N.J. – Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division, Valeria A. Nickerson, and U.S. Attorney for the District of New Jersey, Craig Carpenito announced criminal charges against 17 members, associates, and drug suppliers of a Newark street gang that distributed heroin and crack cocaine...
PRESS RELEASE

Black market pill manufacturing operation dismantled in Bronx apartment building; superintendent among three charged

NEW YORK - Special Agent in Charge James Hunt, New York Division, U.S. Drug Enforcement Administration; Bridget G. Brennan, New York City’s Special Narcotics Prosecutor; New York City Police Commissioner James P. O’Neill; New York State Police Superintendent George P. Beach II; Angel M. Melendez, Special Agent in Charge of...
PRESS RELEASE

Sacramento man charged with international money laundering and multiple indoor marijuana grows

SACRAMENTO, Calif. — A 10-count indictment was unsealed today charging Daniel Zhu, 38, of Sacramento, with conspiracy to commit international money laundering, substantive counts of international money laundering, and conspiracy to manufacture and manufacturing of marijuana, announced Special Agent in Charge Chris Nielsen of the U.S. Drug Enforcement Administration in...
PRESS RELEASE

Fatal overdose in Manhattan leads to arrest of alleged drug dealer in Miami

NEW YORK - Special Agent in Charge James Hunt, New York Division, U.S. Drug Enforcement Administration; Geoffrey S. Berman, the United States Attorney for the Southern District of New York; and James P. O’Neill, the Commissioner of the New York City Police Department, announced today the arrest of Michael Jones...
PRESS RELEASE

New York man sentenced to 14 years for heroin and crack cocaine distribution

BURLINGTON, Vt – Brian D. Boyle, Special Agent in Charge of the DEA’s New England Division and United States Attorney for the District of Vermont Christina Nolan announced that Michael Brockenbaugh, 37, of the Bronx, New York, was sentenced today by United States District Judge Christina Reiss, to a 14-year...
PRESS RELEASE

Retired nurse sentenced to five years in prison for drug trafficking and money laundering

NEW HAVEN, Conn. – Brian D. Boyle, Special Agent in Charge of the DEA’s New England Division, and John H. Durham, United States Attorney for the District of Connecticut, announced that Christine Miles, 59, of Windsor Locks, was sentenced today by U.S. District Judge Jeffrey A. Meyer in New Haven...
PRESS RELEASE

25-plus Chicago defendants face drug charges for alleged fentanyl or fentanyl-laced heroin sales

CHICAGO - More than 25 individuals are facing federal or state drug charges for allegedly selling pure fentanyl or fentanyl-laced heroin in Chicago. Many of the defendants sold narcotics to an undercover law enforcement officer earlier this year, according to the charges. Several of the sales occurred in daytime hours...
PRESS RELEASE

Buffalo man charged with selling fentanyl that caused serious bodily injury

BUFFALO, N.Y. - U.S. Attorney James P. Kennedy, Jr. and Special Agent in Charge James Hunt, U.S. Drug Enforcement Administration, New York Division announced today that a federal grand jury has returned an indictment charging Julian Beavers, a/k/a Ock, a/k/a Marcel Ceasar, a/k/a BJ, 32, of Buffalo, New York, with...
PRESS RELEASE

Colombian veterinarian pleads guilty in Brooklyn federal court to heroin importation conspiracy

BROOKLYN, N.Y. – Andres Lopez Elorez pleaded guilty today before U. S. Magistrate Judge Robert M. Levy in federal court in Brooklyn to conspiring to import heroin into the United States. Richard P. Donoghue, U. S. Attorney for the Eastern District of New York, and James J. Hunt, Special Agent...
PRESS RELEASE

FDA-approved drug Epidiolex placed in schedule V of Controlled Substance Act

WASHINGTON - The Department of Justice and Drug Enforcement Administration today announced that Epidiolex, the newly approved medication by the Food & Drug Administration, is being placed in schedule V of the Controlled Substances Act, the least restrictive schedule of the CSA. In June 2018, the FDA announced it approved...